Have a personal or library account? Click to login
Topical antifungal bigels: Formulation, characterization and evaluation Cover

Topical antifungal bigels: Formulation, characterization and evaluation

Open Access
|Apr 2018

References

  1. 1. Y. C. Chen, D. Z. Liu, J. J. Liu, T. W. Chang, H. O. Ho and M. T. Sheu, Development of terbinafine solid lipid nanoparticles as a topical delivery system, Int. J. Nanomedicine7 (2012) 4409–4418; https://doi.org/10.2147/IJN.S3368210.2147/IJN.S33682342315222923986
  2. 2. I. F. Almeida, A. R. Fernandes, L. Fernandes, M. R. Pena Ferreira, P. C. Costa and M. F. Bahia, Moisturizing effect of oleogel/hydrogel mixtures, Pharm. Dev. Technol.13 (2008) 487–494; https://doi.org/10.1080/1083745080228244710.1080/1083745080228244718720247
  3. 3. S. Bangarwa, S. Garg and A. Aseri, A review on antifungal gels: as a topical drug delivery system, Int. J. Pharm. Technol. Biotechnol.1 (2014) 48–55.
  4. 4. V. K. Singh, I. Banerjee, T. Agarwal, K. Pramanik, M. K. Bhattacharya and K. Pal, Guar gum and sesame oil based novel bigels for controlled drug delivery, Colloids Surfaces B Biointerfaces123 (2014) 582–592; https://doi.org/10.1016/j.colsurfb.2014.09.05610.1016/j.colsurfb.2014.09.05625444661
  5. 5. F. R. Lupi, L. Gentile, D. Gabriele, S. Mazzulla, N. Baldino and B. de Cindio, Olive oil and hyperthermal water bigels for cosmetic uses, J. Colloid Interface Sci.459 (2015) 70–78; https://doi.org/10.1016/j.jcis.2015.08.01310.1016/j.jcis.2015.08.01326263497
  6. 6. M. J. Dolton, V. Perera, L. G. Pont and A. J. McLachlan, Terbinafine in combination with other antifungal agents for treatment of resistant or refractory mycoses: investigating optimal dosing regimens using a physiologically based pharmacokinetic model, Antimicrob. Agents Chemother. 58 (2014) 48–54; https://doi.org/10.1128/AAC.01466-1310.1128/AAC.01466-13391073324145526
  7. 7. M. K. Kathiravan, A. B. Salake, A. S. Chothe, P. B. Dudhe, R. P. Watode, M. S. Mukta, S. Gadhwe, The biology and chemistry of antifungal agents: A review, Bioorg. Med Chem.20 (2012) 5678–5698; https://doi.org/10.1016/j.bmc.2012.04.04510.1016/j.bmc.2012.04.04522902032
  8. 8. K. Tabara, A. E. Szewczyk, W. Bienias, A. Wojciechowska, M. Pastuszka, M. Oszukowska, A. Kaszuba, Amorolfine vs. ciclopirox – Lacquers for the treatment of onychomycosis, Postep. Dermatol. Alergol.32 (2015) 40–45; https://doi.org/10.5114/pdia.2014.4096810.5114/pdia.2014.40968436000925821426
  9. 9. A. Mazurkeviciute, K. Ramanauskiene, M. Ivaskiene, A. Grigonis and V. Briedis, Modelling and biopharmaceutical evaluation of ciclopirox olamine gels, Acta Pol. Pharm.74 (2017) 543–549.
  10. 10. J. Ma, Y. Lin, X. Chen, B. Zhao and J. Zhang, Flow behavior, thixotropy and dynamical viscoelasticity of sodium alginate aqueous solutions, Food Hydrocoll.38 (2014) 119–128; https://doi.org/10.1016/j.foodhyd.2013.11.01610.1016/j.foodhyd.2013.11.016
  11. 11. M. T. Islam, N. Rodriguez-Hornedo, S. Ciotti and C. Ackermann, Rheological characterization of topical carbomer gels neutralized to different pH, Pharm. Res.21 (2004) 1192–1199; https://doi.org/10.1023/B:PHAM.0000033006.11619.0710.1023/B:PHAM.0000033006.11619.07
  12. 12. M. M. Ibrahim, S. A. Hafez and M. M. Mahdy, Organogels, hydrogels and bigels as transdermal delivery systems for diltiazem HCL, Asian J. Pharm. Sci.8 (2013) 46–54; https://doi.org/10.1016/j.ajps.2013.07.00610.1016/j.ajps.2013.07.006
  13. 13. A. Kaur, S. Jaiswal and G. D. Gupta, Formulation and evalution of terbinafine hydrochloride topical gel, Indo. Am. J. Pharm. Res.4 (2014) 2919–2927.
  14. 14. M. E. Herbig and D. H. Evers, Correlation of hydrotropic solubilization by urea with log D of drug molecules and utilization of this effect for topical formulations, Eur. J. Pharm. Biopharm.85 (2013) 158–160; https://doi.org/10.1016/j.ejpb.2013.06.02210.1016/j.ejpb.2013.06.022
  15. 15. J. Leyden, Pharmacokinetics and pharmacology of terbinafine and itraconazole, J. Am. Acad. Dermatol.38 (1998) 42–47; https://doi.org/10.1016/S0190-9622(98)70483-910.1016/S0190-9622(98)70483-9
DOI: https://doi.org/10.2478/acph-2018-0014 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 223 - 233
Accepted on: Dec 21, 2017
Published on: Apr 26, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2018 Agne Mazurkeviciute, Kristina Ramanauskiene, Marija Ivaskiene, Aidas Grigonis, Vitalis Briedis, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.